We thank the following professionals for their much appreciated scientific advice and generous sharing of viruses: Robert B. Tesh of the University of Texas Medical Branch, Galveston, TX; Douglas M. Watts, University of Texas at El Paso, El Paso, TX; and Kenneth Linthicum of the USDA-Center for Medical, Agricultural and Veterinary Entomology, Gainesville, FL. We also thank Kelli Barr, John Paul Burks, Stephen J. Blazs, Clint McDaniel, John Friary, and Yilun Sun, all formerly with the Emerging Pathogens Institute, Igor Morozov DVM, and Karinne K. Cortes of the Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD), Kansas State University, Manhattan, KS, for their numerous contributions and support of this work. Finally, we thank Jean-Pierre Ravalohery and Seta Andriamamonjy, Virology unit, Institut Pasteur of Madagascar, for their technical support during field work and Sedera Andrimasinoro for developing a user-friendly database.
Daubney R, Hudson JR, Garnham PC, 1931. Enzootic hepatitis or Rift Valley fever. An undescribed virus disease of sheep cattle and man from east Africa. J Pathol Bacteriol 34: 545–579.
Centers for Disease Control and Prevention, 2000. Outbreak of Rift Valley fever—Saudi Arabia, August–October, 2000. Morb Mortal Wkly Rep 49: 905–908.
Centers for Disease Control and Prevention, 2000. Outbreak of Rift Valley fever—Yemen, August–October 2000. Morb Mortal Wkly Rep 49: 1065–1066.
Munyua P, Murithi RM, Wainwright S, Githinji J, Hightower A, Mutonga D, Macharia J, Ithondeka PM, Musaa J, Breiman RF, Bloland P, Njenga MK, 2007. Rift Valley fever outbreak—Kenya, November 2006–January 2007. Morb Mortal Wkly Rep 56: 73–76.
Nguku PM, Sharif SK, Mutonga D, Amwayi S, Omolo J, Mohammed O, Farnon EC, Gould LH, Lederman E, Rao C, Sang R, Schnabel D, Feikin DR, Hightower A, Njenga MK, Breiman RF, 2010. An investigation of a major outbreak of Rift Valley fever in Kenya: 2006–2007. Am J Trop Med Hyg 83: 5–13.
Anyangu AS, Gould LH, Sharif SK, Nguku PM, Omolo JO, Mutonga D, Rao CY, Lederman ER, Schnabel D, Paweska JT, Katz M, Hightower A, Njenga MK, Feikin DR, Breiman RF, 2010. Risk factors for severe Rift Valley fever infection in Kenya, 2007. Am J Trop Med Hyg 83: 14–21.
Andriamandimby SF, Randrianarivo-Solofoniaina AE, Jeanmaire EM, Ravololomanana L, Razafimanantsoa LT, Rakotojoelinandrasana T, Razainirina J, Hoffmann J, Ravalohery JP, Rafisandratantsoa JT, Rollin PE, Reynes JM, 2010. Rift Valley fever during rainy seasons, Madagascar, 2008 and 2009. Emerg Infect Dis 16: 963–970.
- Search Google Scholar
- Export Citation
Andriamandimby SF Randrianarivo-Solofoniaina AE Jeanmaire EM Ravololomanana L Razafimanantsoa LT Rakotojoelinandrasana T Razainirina J Hoffmann J Ravalohery JP Rafisandratantsoa JT Rollin PE Reynes JM 2010. Rift Valley fever during rainy seasons, Madagascar, 2008 and 2009. Emerg Infect Dis 16: 963– 970.
Morvan J, Saluzzo JF, Fontenille D, Rollin PE, Coulanges P, 1991. Rift Valley fever on the east coast of Madagascar. Res Virol 142: 475–482.
Morvan J, Rollin PE, Laventure S, Rakotoarivony I, Roux J, 1992. Rift Valley fever epizootic in the central highlands of Madagascar. Res Virol 143: 407–415.
Evans A, Gakuya F, Paweska JT, Rostal M, Akoolo L, Van Vuren PJ, Manyibe T, Macharia JM, Ksiazek TG, Feikin DR, Breiman RF, Kariuki Njenga M, 2008. Prevalence of antibodies against Rift Valley fever virus in Kenyan wildlife. Epidemiol Infect 136: 1261–1269.
LaBeaud AD, Cross PC, Getz WM, Glinka A, King CH, 2011. Rift Valley fever virus infection in African buffalo (Syncerus caffer) herds in rural South Africa: evidence of interepidemic transmission. Am J Trop Med Hyg 84: 641–646.
LaBeaud AD, Muchiri EM, Ndzovu M, Mwanje MT, Muiruri S, Peters CJ, King CH, 2008. Interepidemic Rift Valley fever virus seropositivity, northeastern Kenya. Emerg Infect Dis 14: 1240–1246.
LaBeaud AD, Muiruri S, Sutherland LJ, Dahir S, Gildengorin G, Morrill J, Muchiri EM, Peters CJ, King CH, 2011. Postepidemic analysis of Rift Valley fever virus transmission in northeastern Kenya: a village cohort study. PLoS Negl Trop Dis 5: e1265.
LaBeaud AD, Ochiai Y, Peters CJ, Muchiri EM, King CH, 2007. Spectrum of Rift Valley fever virus transmission in Kenya: insights from three distinct regions. Am J Trop Med Hyg 76: 795–800.
Muiruri S, Kabiru EW, Muchiri EM, Hussein H, Kagondu F, LaBeaud AD, King CH, 2014. Cross-sectional survey of Rift Valley fever virus exposure in Bodhei Village located in a transitional coastal forest habitat in Lamu County, Kenya. Am J Trop Med Hyg 92: 394–400.
Webb PA, Johnson KM, Mackenzie RB, 1969. The measurement of specific antibodies in Bolivian hemorrhagic fever by neutralization of virus plaques. Proc Soc Exp Biol Med 130: 1013–1019.
Paweska JT, Burt FJ, Swanepoel R, 2005. Validation of IgG-sandwich and IgM-capture ELISA for the detection of antibody to Rift Valley fever virus in humans. J Virol Methods 124: 173–181.
Rolin AI, Berrang-Ford L, Kulkarni MA, 2013. The risk of Rift Valley fever virus introduction and establishment in the United States and European Union. Emerg Microbes Infect 2: e81.
Hartley DM, Rinderknecht JL, Nipp TL, Clarke NP, Snowder GD, National Center for Foreign Animal and Zoonotic Disease Defense Advisory Group on Rift Valley Fever, 2011. Potential effects of Rift Valley fever in the United States. Emerg Infect Dis 17: e1.
Memish ZA, Masri MA, Anderson BD, Heil GL, Merrill HR, Khan SU, Alsahly A, Gray GC, 2015. Elevated antibodies against Rift Valley fever virus among humans with exposure to ruminants in Saudi Arabia. Am J Trop Med Hyg 92: 739–743.